Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Picroside Ii
1. Picroside Ii
2. 6-vanilloylcatalpol
3. Ampicoside
4. 39012-20-9
5. Xx0pfp9rvi
6. 1961245-47-5
7. (1as,1bs,2s,5ar,6s,6as)-1a-(hydroxymethyl)-2-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-1a,1b,2,5a,6,6a-hexahydrooxireno[2',3':4,5]cyclopenta[1,2-c]pyran-6-yl 4-hydroxy-3-methoxybenzoate
8. Amphicoside Ii
9. [(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl] 4-hydroxy-3-methoxybenzoate
10. [2-(hydroxymethyl)-10-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl] 4-hydroxy-3-methoxybenzoate
11. Beta-d-glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-((4-hydroxy-3-methoxybenzoyl)oxy)-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1as-(1aalpha,1bbeta,2beta,5abeta,6beta,6aalpha))-
12. Einecs 254-247-6
13. Unii-xx0pfp9rvi
14. Chembl510404
15. Megxp0_001244
16. Acon1_001520
17. Dtxsid30904845
18. Hy-n0408
19. Zinc8382348
20. S3765
21. Akos037514782
22. Ccg-269786
23. Ncgc00180420-01
24. Ncgc00180420-03
25. Ncgc00180420-04
26. Cs-0008940
27. Q-100453
28. Brd-k40184968-001-01-7
29. (1as,1bs,2s,5ar,6s,6as)-1a,1b,2,5a,6,6a-hexahydro-6-((4-hydroxy-3-methoxybenzoyl)oxy)-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl .beta.-d-glucopyranoside
30. (1as,1bs,2s,5ar,6s,6as)-1a,1b,2,5a,6,6a-hexahydro-6-((4-hydroxy-3-methoxybenzoyl)oxy)-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl Beta-d-glucopyranoside
31. .beta.-d-glucopyranoside, (1as,1bs,2s,5ar,6s,6as)-1a,1b,2,5a,6,6a-hexahydro-6-((4-hydroxy-3-methoxybenzoyl)oxy)-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl
32. .beta.-d-glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-((4-hydroxy-3-methoxybenzoyl)oxy)-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1as-(1a.alpha.,1b.beta.,2.beta.,5a.beta.,6.beta.,6a.alpha.))-
33. Beta-d-glucopyranoside, (1as,1bs,2s,5ar,6s,6as)-1a,1b,2,5a,6,6a-hexahydro-6-((4-hydroxy-3-methoxybenzoyl)oxy)-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl
34. Ncgc00180420-03_c23h28o13_(1as,1bs,2s,5ar,6s,6as)-2-(beta-d-glucopyranosyloxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-6-yl 4-hydroxy-3-methoxybenzoate
| Molecular Weight | 512.5 g/mol |
|---|---|
| Molecular Formula | C23H28O13 |
| XLogP3 | -1.4 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 8 |
| Exact Mass | 512.15299094 g/mol |
| Monoisotopic Mass | 512.15299094 g/mol |
| Topological Polar Surface Area | 197 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 839 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
91
PharmaCompass offers a list of Picroside II API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Picroside II manufacturer or Picroside II supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Picroside II manufacturer or Picroside II supplier.
PharmaCompass also assists you with knowing the Picroside II API Price utilized in the formulation of products. Picroside II API Price is not always fixed or binding as the Picroside II Price is obtained through a variety of data sources. The Picroside II Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Picroside II manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Picroside II, including repackagers and relabelers. The FDA regulates Picroside II manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Picroside II API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Picroside II supplier is an individual or a company that provides Picroside II active pharmaceutical ingredient (API) or Picroside II finished formulations upon request. The Picroside II suppliers may include Picroside II API manufacturers, exporters, distributors and traders.
Picroside II Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Picroside II GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Picroside II GMP manufacturer or Picroside II GMP API supplier for your needs.
A Picroside II CoA (Certificate of Analysis) is a formal document that attests to Picroside II's compliance with Picroside II specifications and serves as a tool for batch-level quality control.
Picroside II CoA mostly includes findings from lab analyses of a specific batch. For each Picroside II CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Picroside II may be tested according to a variety of international standards, such as European Pharmacopoeia (Picroside II EP), Picroside II JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Picroside II USP).
